Masimo Corporation (MASI) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $178.39. It has a SharesGrow Score of 50/100, indicating a mixed investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of MASI = $80.47 (-54.9% from the current price, the stock appears overvalued). Analyst consensus target is MASI = $188 (+5.1% upside).
Valuation: MASI trades at a trailing Price-to-Earnings (P/E) of -63.1 (S&P 500 average ~25).
Financials: revenue is $1.5B, -8.1%/yr average growth. Net income is $152M (loss), growing at -155.7%/yr. Net profit margin is -9.9% (negative). Gross margin is 61.9% (+9.9 pp trend).
Balance sheet: total debt is $559M against $721M equity (Debt-to-Equity (D/E) ratio 0.78, moderate). Current ratio is 2.49 (strong liquidity). Debt-to-assets is 32.9%. Total assets: $1.7B.
Analyst outlook: 14 / 23 analysts rate MASI as buy (61%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 83/100 (Pass), Moat 74/100 (Pass), Future 61/100 (Pass), Income 10/100 (Fail).
